作者: Bianca K. Verlinden , Abraham Louw , Lyn-Marié Birkholtz
DOI: 10.1517/17460441.2016.1154037
关键词:
摘要: ABSTRACTIntroduction: Currently, widely used antimalarial drugs have a limited clinical lifespan due to parasite resistance development. With continuously rising, drug discovery requires strategies decrease the time of delivering new while simultaneously increasing drug’s therapeutic lifespan. Lessons learnt from various chemotherapeutic studies in fields antibiotic and cancer research offer potentially useful that can be applied discovery.Areas covered: In this review authors discuss current circumvent malaria alternatives could employed.Expert opinion: Scientists been ‘beating back’ with novel for past 49 years but constant rise is forcing community explore alternative strategies. Avant-garde anti-resistance may assist our endeavors t...